Journals / Van Tıp Dergisi / 2021 / Cilt: 28 - Sayı: 2

Comparison of LISA and INSURE Methods in Surfactant Application in Preterm Babies with Respiratory Distress Syndrome

Respiratuvar Distres Sendromlu Preterm Bebeklerde Sürfaktan Uygulanmasında LISA ve INSURE Yöntemlerinin Karşılaştırılması

Pages
232–237
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In the LISA group, it was found that intubation was significantly lower in the first 72 hours in terms of flow.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: This study was conducted to compare the use of surfactant by invasive (intubation tube) and less invasive (thin catheter) methods in preterm babies who received surfactant treatment with the diagnosis of respiratory distress syndrome.
📊
Key Findings & Data:Materials and methods: Hospitalized in the Neonatal Intensive Care unit; The babies whose gestational week was 32nd gestational week and/or below and who needed surfactant treatment were included in the study.
💡
Conclusion & Impact:In the LISA group, it was found that intubation was significantly lower in the first 72 hours in terms of flow.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: This study was conducted to compare the use of surfactant by invasive (intubation tube) and less invasive (thin catheter) methods in preterm babies who received surfactant treatment with the diagnosis of respiratory distress syndrome. Materials and methods: Hospitalized in the Neonatal Intensive Care unit; The babies whose gestational week was 32nd gestational week and/or below and who needed surfactant treatment were included in the study. Sixty patients who needed surfactant replacement for respiratory distress syndrome were included in the study. Poractant alfa (200 mg/kg/dose) was given to all cases. The cases were randomized into LISA (less invasive surfactant administration) and INSURE (Intubation, Surfactant application and Extubation) group. Results: During the administration of surfactant, no complications were observed in 90% of the patients in the INSURE group and in 63.3% of the patients in the LISA group. In the LISA group, it was found that intubation was significantly lower in the first 72 hours in terms of flow. It was found that the need for mechanical ventilation and mortality rates were higher in INSURE. No citations were found among the groups when he asked for repeated surfactant. There was no significant feature among the groups in terms of Respiratory distress syndrome complications (Necrotizing enterocolitis, Intracranial hemorrhage, Retinopathy of Prematurity, Bronchopulmonary dysplasia). Conclusion: Both methods can be used in surfactant replacement therapy, but desaturation is more common during surfactant treatment with a thin catheter. Application difficulties of the catheter method are the disadvantages of the method. However, it seems more successful than the INSURE method because it does not require intubation and positive pressure ventilation, the need for mechanical ventilation support and the duration of stay in mechanical ventilation is less.

Özet

Amaç: Bu çalıs ma, respiratuvar distres sendromu tanısıyla sürfaktan tedavisi uygulanan prematüre bebeklerde, invaziv (entübasyon tüpü) ve daha az invaziv (ince kateter) yöntemlerle sürfaktan uygulanmasının kars ılas tırılması amacıyla yapıldı. Gereç ve yöntem: Yenidog an Yog un Bakım ünitesinde yatan; dog um haftası 32. gebelik haftası ve/veya altında olan ve sürfaktan tedavisi verilmesi gereken bebekler çalıs maya alındı. Respiratuvar distres sendromu için sürfaktan replasmanı gereken 60 olgu çalışmaya alındı. Tüm olgulara poractant alfa (200 mg/kg/doz) verildi. Olgular, LISA (Daha az invaziv sürfaktan uygulaması) ve INSURE (Entübasyon, Sürfaktan uygulaması ve Ekstübasyon) grubu olacak şekilde randomize edildi. Bulgular: Sürfaktan verilis i sırasında INSURE grubundaki hastaların %90’ında, LISA grubundaki hastaların ise %63.3’ünde komplikasyon gözlenmedi. LISA grubunda ilk 72 saatte entübasyon ihtiyacının istatistiksel olarak anlamlı oranda daha düşük olduğu saptandı. Mekanik ventilasyon ihtiyacının ve ölüm oranlarının INSURE grubunda daha yüksek olduğu saptandı. Tekrarlayan sürfaktan ihtiyacı açısından gruplar arasında anlamlı farklılık bulunmadı. Gruplar arasında Respiratuvar distres sendromu komplikasyonları (Nekrotizan enterokolit, İntrakraniyal kanama, Prematüre retinopatisi, Bronkopulmoner displazi) yönünden istatistiksel olarak anlamlı farklılık bulunmadı. Sonuç: Sürfaktan replasman tedavisinde her iki yöntem de uygulanabilir ancak ince kateter ile sürfaktan tedavisi sırasında desatürasyon daha sık görülmektedir. Kateter yönteminin uygulama zorlukları yöntemin dezavantajlarıdır. Fakat entübasyon ve pozitif basınçlı ventilasyon gerektirmemesi, mekanik ventilasyon destek ihtiyacının ve mekanik ventilasyonda kalış süresinin daha az olması nedeniyle INSURE yöntemine göre daha başarılı görünmektedir.

🔖

Cite This Article

AYDIN, N., DEĞER, İ., BAŞARNOĞLU, M., DEMİR, N., TUNCER, O. (2022). Comparison of LISA and INSURE Methods in Surfactant Application in Preterm Babies with Respiratory Distress Syndrome. Van Tıp Dergisi, Cilt: 28 - Sayı: 2, 232–237. https://ajindex.com/articles/645941

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Committee on Fetus and Newborn; American Academy of Pediatrics. Respiratory support in preterm infants at birth. Pediatrics 2014; 133(1): 171-174
  2. Sweet DG, Carnielli V, Greisen G, at al. European Consensus Guidelines on the Management of Respiratory Distress Syndrome. Neonatology 2019; 115: 432-450
  3. Verder H. Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. N Engl J Med 1994; 331(16): 1051-1055
  4. Venkatesh V, Ponnusamy V, Anandaraj J, at al. Endotracheal intubation in a neonatal population remains associated with a high risk of adverse events. Eur J Pediatr 2011; 170(2): 223-227
  5. Sandri F, Plavka R, Ancora G. CURPAP study group. Prophylactic or early selective surfactant combined with nCPAP in very preterm infants. Pediatrics 2010; 125(6): e1402-1409
  6. Kribs A, Pillekamp F, Hünseler C, Vierzig A, Roth B. Early administration of surfactant in spontaneous breathing with nCPAP: feasibility and outcome in extremely premature infants (postmenstrual age 7. Göpel V. Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants: an open-label, randomized, controlled trial. Lancet 2011(9803); 5: 1627-1634
  7. More K, Sakhuja P, Shah PS. Minimally invasive surfactant administration in preterm infants: a meta-narrative review. JAMA Pediatr 2014; 168(10): 901-908
  8. Kanmaz H, Erdeve O, Canpolat F, Mutlu B. Surfactant administration via thin catheter during spontaneous breathing: Randomized clinical trial. Pediatrics 2013; 131(2): 502-509
  9. Shim GH. Update of minimally invasive surfactant therapy. Korean J Pediatr 2017; 60(9): 273-281
  10. Minocchieri S, Berry CA, Pillow JJ; CureNeb Study Team. Nebulised surfactant to reduce severity of respiratory distress: a blinded, parallel, randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 2019; 104(3): F313-319
  11. Herting E, Härtel C, Göpel W. Less invasive surfactant administration (LISA): chances and limitations. Arch Dis Child Fetal Neonatal Ed 2019; 104(6): F655-659
  12. Aldana-Aguirre JC, Pinto M, Featherstone RM, Kumar M. Less invasive surfactant administration versus intubation for surfactant delivery in preterm infants with respiratory distress syndrome: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed 2017; 102(1): F17-23
  13. McElrath TF, Colon I, Hecht J, Tanasijevic MJ, Norwitz ER. Neonatal respiratory distress syndrome as a function of gestational age and